1. BorovitskiyVS (2012). Fibro-cavernous pulmonary tuberculosis. Penitentiary aspects [Fibrozno-kavernoznyy tuberkulez legkikh. Penitentsiarnye aspekty]. Tuberkulez i bolezni legkikh, (9), 3-15.
2. Kazenniy BY, KiselevaYY, IkonnikovaTV (2014).Approach to the treatment of patients with tuberculosis with multidrug resistance of the pathogen in the Orel region [Podkhod k lecheniyu patsientov s tuberkulezom s mnozhestvennoy lekarstvennoy ustoychivost’yu vozbuditelya v Orlovskoy oblasti]. Tuberkulez i bolezni legkikh. (1), 14-21
3. KapkovLP (2014). Why are there more TB patients with multi-drug resistant pathogen? [Pochemu bol’nykh tuberkulezom s mnozhestvennoy lekarstvennoy ustoychivost’yu vozbuditelya stanovitsya bol’she?]. Tuberkulez i bolezni legkih. (11), 11-17.
4. MarkelovYM, MarjandyshevAO (2013). Role of amplification of drug resistance in the formation of acquired multidrug resistance [Rol’ amplifikatsii lekarstvennoy ustoychivosti v formirovanii priobretennoy mnozhestvennoy lekarstvennoy ustoychivosti]. Tuberkulez i bolezni legkih. (7), 22-27.
5. PopovSA, PuzanovVA, SabgajdaTP (2011). Problems of monitoring of drug-resistant tuberculosis in the Russian Federation. The evaluation of the first cycle of monitoring [Problemy monitoringa tuberkuleza s lekarstvennoj ustojchivost’ju v Rossijskoj Federacii. Ocenka rezul’tatov pervogo cikla monitoringa]. Tuberkulez i bolezni legkih. (10), 16-21
6. UstjuzhaninaES, KibrikBS, SosninaOY (2011). Critically increasing chemoresistance of Mycobacterium tuberculosis and possible prospects of increase of efficiency of treatment of new cases of destructive pulmonary tuberculosis [Kriticheski narastajushhaja himiorezistentnost’ mikobakterij tuberkuleza i vozmozhnye perspektivy povyshenija jeffektivnosti lechenija vpervye vyjavlennyh bol’nyh destruktivnym tuberkulezom legkih]. Tuberkulez i bolezni legkih. (5), 196-197
